346 related articles for article (PubMed ID: 30078599)
1. Investigation of immune cell markers in feline oral squamous cell carcinoma.
Sparger EE; Murphy BG; Kamal FM; Arzi B; Naydan D; Skouritakis CT; Cox DP; Skorupski K
Vet Immunol Immunopathol; 2018 Aug; 202():52-62. PubMed ID: 30078599
[TBL] [Abstract][Full Text] [Related]
2. Increased number of CD25 FoxP3 regulatory T cells in oral squamous cell carcinomas detected by chromogenic immunohistochemical double staining.
Schwarz S; Butz M; Morsczeck C; Reichert TE; Driemel O
J Oral Pathol Med; 2008 Sep; 37(8):485-9. PubMed ID: 18355177
[TBL] [Abstract][Full Text] [Related]
3. Characterization of STAT3 expression, signaling and inhibition in feline oral squamous cell carcinoma.
Brown ME; Bear MD; Rosol TJ; Premanandan C; Kisseberth WC; London CA
BMC Vet Res; 2015 Aug; 11():206. PubMed ID: 26272737
[TBL] [Abstract][Full Text] [Related]
4. Histologic, immunohistochemical, and in situ hybridization study of myxoid stroma in feline oral squamous cell carcinoma.
Mineshige T; Tanaka Y; Watanabe K; Tagawa M; Tomihari M; Kobayashi Y
J Vet Med Sci; 2024 Mar; 86(3):258-265. PubMed ID: 38233195
[TBL] [Abstract][Full Text] [Related]
5. Skewed immunological balance between Th17 (CD4(+)IL17A (+)) and Treg (CD4 (+)CD25 (+)FOXP3 (+)) cells in human oral squamous cell carcinoma.
Gaur P; Qadir GA; Upadhyay S; Singh AK; Shukla NK; Das SN
Cell Oncol (Dordr); 2012 Oct; 35(5):335-43. PubMed ID: 22956260
[TBL] [Abstract][Full Text] [Related]
6. Study of feline oral squamous cell carcinoma: potential target for cyclooxygenase inhibitor treatment.
DiBernardi L; Doré M; Davis JA; Owens JG; Mohammed SI; Guptill CF; Knapp DW
Prostaglandins Leukot Essent Fatty Acids; 2007 Apr; 76(4):245-50. PubMed ID: 17383864
[TBL] [Abstract][Full Text] [Related]
7. Dynamics of regulatory T cells (T
Aggarwal S; Sharma SC; N Das S
J Surg Oncol; 2017 Dec; 116(8):1103-1113. PubMed ID: 28833201
[TBL] [Abstract][Full Text] [Related]
8. Patients with oral squamous cell carcinoma are characterized by increased frequency of suppressive regulatory T cells in the blood and tumor microenvironment.
Gasparoto TH; de Souza Malaspina TS; Benevides L; de Melo EJ; Costa MR; Damante JH; Ikoma MR; Garlet GP; Cavassani KA; da Silva JS; Campanelli AP
Cancer Immunol Immunother; 2010 Jun; 59(6):819-28. PubMed ID: 20012605
[TBL] [Abstract][Full Text] [Related]
9. A novel MCT1 and MCT4 dual inhibitor reduces mitochondrial metabolism and inhibits tumour growth of feline oral squamous cell carcinoma.
Khammanivong A; Saha J; Spartz AK; Sorenson BS; Bush AG; Korpela DM; Gopalakrishnan R; Jonnalagadda S; Mereddy VR; O'Brien TD; Drewes LR; Dickerson EB
Vet Comp Oncol; 2020 Sep; 18(3):324-341. PubMed ID: 31661586
[TBL] [Abstract][Full Text] [Related]
10. Forkhead box-P3
Hussaini HM; Parachuru VPB; Seymour GJ; Rich AM
Acta Histochem; 2017 Apr; 119(3):205-210. PubMed ID: 28174027
[TBL] [Abstract][Full Text] [Related]
11. Tumour infiltrating CD25+ FoxP3+ regulatory T cells (Tregs) relate to tumour grade and stromal inflammation in oral squamous cell carcinoma.
Al-Qahtani D; Anil S; Rajendran R
J Oral Pathol Med; 2011 Sep; 40(8):636-42. PubMed ID: 21352381
[TBL] [Abstract][Full Text] [Related]
12. CD45RA
Ihara F; Sakurai D; Horinaka A; Makita Y; Fujikawa A; Sakurai T; Yamasaki K; Kunii N; Motohashi S; Nakayama T; Okamoto Y
Cancer Immunol Immunother; 2017 Oct; 66(10):1275-1285. PubMed ID: 28551813
[TBL] [Abstract][Full Text] [Related]
13. Fatty acid synthase as a potential therapeutic target in feline oral squamous cell carcinoma.
Walz JZ; Saha J; Arora A; Khammanivong A; O'Sullivan MG; Dickerson EB
Vet Comp Oncol; 2018 Mar; 16(1):E99-E108. PubMed ID: 28871635
[TBL] [Abstract][Full Text] [Related]
14. Immunophenotyping of patients with oral squamous cell carcinoma in peripheral blood and associated tumor tissue.
Grimm M; Feyen O; Hofmann H; Teriete P; Biegner T; Munz A; Reinert S
Tumour Biol; 2016 Mar; 37(3):3807-16. PubMed ID: 26474587
[TBL] [Abstract][Full Text] [Related]
15. Tumor-infiltrating lymphocytes, particularly the balance between CD8(+) T cells and CCR4(+) regulatory T cells, affect the survival of patients with oral squamous cell carcinoma.
Watanabe Y; Katou F; Ohtani H; Nakayama T; Yoshie O; Hashimoto K
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 May; 109(5):744-52. PubMed ID: 20303300
[TBL] [Abstract][Full Text] [Related]
16. CD45RA-Foxp3high but not CD45RA+Foxp3low suppressive T regulatory cells increased in the peripheral circulation of patients with head and neck squamous cell carcinoma and correlated with tumor progression.
Sun W; Li WJ; Wu CY; Zhong H; Wen WP
J Exp Clin Cancer Res; 2014 Apr; 33(1):35. PubMed ID: 24761979
[TBL] [Abstract][Full Text] [Related]
17. COX-1 and COX-2 expression in feline oral squamous cell carcinoma.
Hayes A; Scase T; Miller J; Murphy S; Sparkes A; Adams V
J Comp Pathol; 2006; 135(2-3):93-99. PubMed ID: 16952367
[TBL] [Abstract][Full Text] [Related]
18. CD4+CD25hiCD127low regulatory T cells are increased in oral squamous cell carcinoma patients.
Lim KP; Chun NA; Ismail SM; Abraham MT; Yusoff MN; Zain RB; Ngeow WC; Ponniah S; Cheong SC
PLoS One; 2014; 9(8):e103975. PubMed ID: 25153698
[TBL] [Abstract][Full Text] [Related]
19. Characterization of immune cell infiltrate in tumor stroma and epithelial compartments in oral squamous cell carcinomas of Sudanese patients.
Gaafar NM; Osman TA; Ahmed IA; Elsheikh M; Dongre H; Jacobsen MR; Mohamed NG; Fromreide S; Suleiman AM; Johannessen AC; Nginamau ES; Costea DE
Clin Exp Dent Res; 2022 Feb; 8(1):130-140. PubMed ID: 34626165
[TBL] [Abstract][Full Text] [Related]
20. Bone-invasive oral squamous cell carcinoma in cats: pathology and expression of parathyroid hormone-related protein.
Martin CK; Tannehill-Gregg SH; Wolfe TD; Rosol TJ
Vet Pathol; 2011 Jan; 48(1):302-12. PubMed ID: 20940448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
